Dr. Heny Brem


Dr. Henry Brem is the Harvey Cushing Professor of Neurosurgery at the Johns Hopkins University, Director of the Department of Neurosurgery, and Neurosurgeon-in-Chief. He also is a professor of Oncology, Ophthalmology, and Biomedical Engineering. 

Dr. Brem has developed techniques that have forever changed the field of neurosurgery.  Dr. Brem carried out an important clinical study that helped introduce navigational imaging into the neurosurgical field. 

Furthermore, he has changed the surgical techniques used against brain tumors by inventing and developing Gliadel® wafers to intraoperatively deliver chemotherapy to brain tumors.  This new drug delivery system has shown that surgeons can accurately deliver medications directly at the tumor site.

Dr. Henry Brem has changed the surgical treatment of brain tumors by introducing new approaches for drug delivery systems and targeted therapy.  One of the ways that he has done this is by designing and leading the clinical trials demonstrating safety and efficacy of these new drug delivery systems. Brem used his laboratory experience to design and lead many multi-institutional clinical trials that prove the safety and efficacy of this drug delivery system for patients with tumors. In fact, Dr. Berm will be a Plenary speaker at the MIT 14th Us-Japan Symposium on Drug Delivery Systems Symposiums on the advances in brain tumor therapy.

In 2000, Brem was named director of the Department of Neurosurgery at Johns Hopkins. Since his appointment, Brem has been pushing research boundaries to enhance patient’s outcomes in the field of neurosurgery. His commitment to patient care is further demonstrated by being a founding member of the Armstrong Institute for Patient Safety and Quality.




Dr. Joseph DeSimone

Joseph DeSimone, a professor of Chemistry at UNC-Chapel Hill and William Kenan Jr. Professor of Chemical Engineering at N.C. State, will be a Plenary Speakers at the 14th US-Japan Symposium on Drug Delivery Systems on Advances in Imprint Lithography and Additive Manufacturing for Drug Delivery Systems.

DeSimone achievements include publishing over two hundred and seventy scientific articles and holds one hundred and twenty patents with over one hundred patents pending. He also received over fifty major awards including:
In 2002, with Dr. Richard Stack from Duke University and Dr. Robert Langer from MIT, DeSimone co-founded BVS. BVS stands for Bioabsorbable Vascular Solutions which is a fully bioabsorbable, drug-eluting stent. In 2011 this stent received the European CE Mark approval. It is currently being evaluated further in numerous clinical trials.
DeSimone is one of the few people that has membership in all three U.S. National Science Academies:
On TED2015, Joseph DeSimone has spoken on the popular topic of 3D printing. In his speech he unveiled a new 3D printing technique that is twenty-five to one hundred times faster. Joseph DeSimone made breakthrough contributions in 3D Printing. He co-founded a 3D printing company in Silicon Valley called Carbon 3D in 2003 and helped create the new CLIP 3D printing system. Though it’s not the only company he’s founded. He's the co-founder of several companies, including Micell Technologies, Bioabsorbable Vascular Solutions, Liquidia Technologies and Carbon3D.